ArticleThe journal of headache and pain2025
Tear fluid CGRP rises during glyceryl trinitrate-induced headache in migraine patients.
Article in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Tear Fluid Calcitonin Gene-Related Peptide Levels Are Elevated in Glycerol Trinitrate-Induced Cluster Headache Attacks: Results From an Exploratory Study.European journal of neurology · 2026Article
- Tear fluid Calcitonin gene-related peptide in patients with idiopathic intracranial hypertension headache - a prospective case-control study.The journal of headache and pain · 2026Article
- Tear fluid calcitonin gene-related peptide (CGRP) is elevated during spontaneous migraine attacks - results from a pilot study.The journal of headache and pain · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCalcitonin gene-related peptide (CGRP) plays an important role in migraine pathophysiology and is a marker of trigeminal activity. We investigated tear fluid CGRP levels interictally and ictally using the glyceryl trinitrate (GTN) experimental migraine model.
methodsStudy participants were assessed interictally and during an experimental headache using GTN. Interictal tear fluid CGRP levels were assessed in episodic migraine (EM) patients and healthy controls (HC). At the day of experimental headache, tear fluid was sampled in EM patients before and after intravenous GTN application. Participants were free to use their usual abortive medication if needed. Tear fluid CGRP levels were analyzed using two different ELISAs.
results26 EM patients and 20 healthy controls were examined interictally. Interictal tear fluid CGRP was significantly higher in EM patients compared to HCs (Abbexa® CGRP ELISA: interictal EM patients: 2.78 ± 1.99 ng/ml, HC: 1.35 ± 0.78 ng/ml, U = -2.969, p = 0.003). 17 EM patients were analyzed after intravenous GTN. Tear fluid CGRP levels were significantly elevated at maximum headache compared to baseline (Abbexa® CGRP ELISA: 3.84 ± 1.96 ng/ml vs. 2.78 ± 2.38 ng/ml, p = 0.025; Cusabio® CGRP ELISA: 1.43 ± 0.96 ng/ml vs. 0.75 ± 0.77 ng/ml, p < 0.001). Seven patients developed a headache with an intensity ≥ 5 on the numerical rating scale (NRS) and showed a significantly higher rise in tear fluid CGRP compared to patients with a headache < 5 on the NRS (Abbexa® CGRP ELISA: + 2.11 ± 2.14 ng/ml vs. + 0.32 ± 1.33 ng/ml, p = 0.033; Cusabio® CGRP ELISA: + 1.45 ± 0.81 ng/ml vs. + 0.09 ± 0.53 ng/ml; p < 0.001). Tear fluid CGRP levels were significantly more reduced after intake of abortive medication than after spontaneous headache improvement (Abbexa® CGRP ELISA: -0.82 ± 1.26 ng/ml vs. 1.24 ± 2.06 ng/ml, p = 0.014; Cusabio® CGRP ELISA: -0.66 ± 1.27 ng/ml vs. -0.12 ± 0.24 ng/ml, p = 0.033).
conclusionThe present results demonstrate validity of tear fluid CGRP assessment during experimental migraine, detecting a rise of tear fluid CGRP levels during GTN-induced headache. The intake of abortive medication reduced tear fluid CGRP levels significantly more than spontaneous headache improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.